Fayette, J., Fontaine-Delaruelle, C., Ambrun, A., Daveau, C., Poupart, M., Ramade, A., . . . Céruse, P. (2016). Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: A study of 48 patients. Oncotarget.
Styl ChicagoFayette, Jérôme, et al. "Neoadjuvant Modified TPF (docetaxel, Cisplatin, Fluorouracil) for Patients Unfit to Standard TPF in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Study of 48 Patients." Oncotarget 2016.
Citace podle MLAFayette, Jérôme, et al. "Neoadjuvant Modified TPF (docetaxel, Cisplatin, Fluorouracil) for Patients Unfit to Standard TPF in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Study of 48 Patients." Oncotarget 2016.